This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Thursday's Winners & Losers: Hologix

Orthopedic product maker Orthofix International NV (OFIX - Get Report) said Thursday that its first-quarter profit fell to $3.6 million, or 21 cents a share, from $6.3 million, or 37 cents a share, in the year-ago period.

Revenue rose 9% to $128 million from $117 million, beating expectations of analysts polled by Thomson Financial who expected profit of 9 cents a share on revenue of $122.5 million. The beat prompted a 12% rise in the stock, to $34.50.

Costa Mesa, Calif.-based Volcom (VLCM), which makes apparel for young men and young women, jumped 26% to $23.95 on first-quarter earnings of $9.3 million, or 38 cents a share, vs. $5.5 million, or 22 cents a share, a year ago. Analysts polled by Thomson Financial were looking for 21 cents a share.

Advanced Medical Optics (EYE) said its first-quarter net profit was $6.9 million, or 11 cents a share, down from $12.1 million, or 20 cents a share, a year earlier. Factoring out acquisition and restructuring charges, the company earned 22 cents a share, on net sales to $303.7 million.

Analysts surveyed by Thomson Financial were looking for 22 cents a share, on revenue of $294.6 million. Shares rose 11.5% to $23.42.

Medical technology company Hologix (HOLX - Get Report), which recently completed a 2-for-1 stock split, plummeted 18.6% to $23.75 Thursday after the company aired its second-quarter results. Revenue climbed to $431 million from $181.1 million. Hologic reported net income of $56 million, or 22 cents a share a share -- and adjusted profit of $76.2 million, vs. $24 million a year prior.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
GRZ $2.91 0.00%
OFIX $35.96 0.00%
HOLX $33.14 0.00%
YHOO $44.36 0.00%
TSLA $231.55 0.00%


DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs